A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection.

Ítems similars

• Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.
  per: Dowbenko, D, et al.
  Publicat: (1988)
• Antibody-Dependent Cellular Cytotoxicity Directed against Cells Expressing Human Immunodeficiency Virus Type 1 Envelope of Primary or Laboratory-Adapted Strains by Human and Chimpanzee Monoclonal Antibodies of Different Epitope Specificities
  per: Alsmadi, Osama, et al.
  Publicat: (1998)
• A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody.
  per: Warrier, S V, et al.
  Publicat: (1994)
• Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
  per: Ho, D D, et al.
  Publicat: (1991)
• Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.
  per: Vijh-Warrier, S, et al.
  Publicat: (1996)